SID & GP strengthens interaction between international regulators
On September 6, 2018 Vladislav Shestakov – Deputy Head of the Russian Inspectorate, Director of the State Institute of Drugs and Good Practices of the Russian Ministry of Industry and Trade – was on a business tour in Italy.
As part of the trip, he visited the Fedegari production facility, where Vladislav Shestakov had a professional meeting with Giuseppe Fedegari (Head of the Fedegari Group), Gilbert Ferraroli (CEO of the company Fedegari), Pierre Winnipins (founder of the No Deviation), and Yaroslav Anfossi (Fedegari’s sales manager).
The parties discussed opportunities of organizing educational and training workshops for inspectorates of the two countries.
‘The Russian GMP-inspectorate complies with the norms and rules of countries that enjoy high quality control system: we are making every effort to create a trustworthy image of our inspectors and secure global outreach. These days it is vital to exchange experience and discuss existing opportunities for development and interaction. The “Pharma 2030” strategy has an ambitious goal to increase export potential tenfold. We are strengthening interaction between international regulators, which will contribute to enhancement of export capacity of both countries,’ said Vladislav Shestakov.
Deputy Head of the Russian inspectorate suggested scheduling an educational workshop on aseptic manufacturing for GMP inspectors of Russia, Belarus, Kazakhstan, Kyrgyzstan, and Armenia in either Russia or Italy. Thematic seminars for international inspectorates should be planned on an ongoing basis.
Other materials
- International Forum of Pharmaceutical Inspectorates: A Step Towards Global Harmonization of Standards
- FSI “SID & GP” and CDSCO, India signed a cooperation agreement.
- The importance of reference samples in the development of pharmaceutical industry was discussed during the meeting of the Healthcare Commission of the General Council of the UNITED RUSSIA Party
- The program of the IX All-Russian GMP Conference with international participation has been published
- Attendees of the ‘Ensuring Drug Security’ Forum discussed issues of public trust in the Russian pharmaceutical products